Health tech company Cadence manages 100,000 chronic disease patients with remote, AI-powered monitoring. When a patient's vitals are dangerous, a voice agent calls them within minutes to triage symptoms and escalate care, catching approximately 20 strokes per week before they become critical.

The core of value-based care is a business model where preventing adverse events like strokes is more profitable than treating them. This fundamental financial alignment, not just quality measures, drives organizations like Kaiser to invest in team-based care and proactive protocols, a reality that clinicians within the system may not even perceive.

Coursera Health's strategy is a two-pronged approach that combines distinct technologies. It uses a deep causal AI tool to predict an individual's lifetime cardiovascular risk, then deploys a once-annual RNAi therapeutic to prevent that risk from materializing. This integration of prediction and prevention targets healthy individuals long before disease onset.

Current healthcare is a 'sick care' system that reacts to problems after they arise. AI health agents, by continuously integrating data from wearables, environment, and even smart appliances, can identify baseline health and prompt proactive behaviors to optimize wellness and prevent disease from occurring.

The idea of preventing disease by managing measurable risks like cholesterol was a paradigm shift in medicine, born from observing 5,000 residents of Framingham, MA over decades, an unprecedented study that began in 1948.

Chronic illnesses like cancer, heart disease, and Alzheimer's typically develop over two decades before symptoms appear. This long "runway" is a massive, underutilized opportunity to identify high-risk individuals and intervene, yet medicine typically focuses on treatment only after a disease is established.

Coursera Health's approach wasn't feasible a decade ago. Its existence depends on the recent convergence of three critical technologies: advanced AI for predictive modeling, mature RNAi therapeutics for safe and durable intervention, and large-scale longitudinal datasets like the UK Biobank to train the predictive models accurately.

Healthcare systems were designed for acute, symptomatic diseases. This "wait for the patient" model is ineffective for chronic conditions like hypertension, which are often asymptomatic for years. The future requires a shift from sporadic visits to continuous, proactive, tech-enabled care.

The current healthcare model is backwards. It's more cost-effective to proactively get comprehensive diagnostics like blood work done twice a year than to rely on multiple, expensive doctor visits after symptoms appear. This preventative approach catches diseases earlier and reduces overall system costs.